Factor XIII (FXIII) activity was lower in samples collected during acute episodes of atypical hemolytic uremic syndrome (aHUS), while…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Developing atypical hemolytic uremic syndrome (aHUS) complicated the recovery of a baby boy with typical hemolytic uremic syndrome (HUS)…
A woman with atypical hemolytic uremic syndrome (aHUS) developed severe complications affecting the kidneys, brain, and heart, but recovered…
A man who developed a severe, full-body flare of psoriasis that caused his skin to peel and swell and triggered…
A previously healthy young man in Greece who later developed atypical hemolytic uremic syndrome (aHUS) improved rapidly after being…
A 4-year-old boy developed post-infectious glomerulonephritis (PIGN) and later atypical hemolytic uremic syndrome (aHUS), both of which affect the…
Prompt and intensive supportive care, which included plasma exchange and Soliris (eculizumab), successfully reversed organ failure…
Soliris (eculizumab) helped ease disease symptoms for a woman with multiple myeloma who developed atypical hemolytic uremic syndrome…
Soliris (eculizumab) is safe and effective for treating children with various types of hemolytic uremic syndrome (HUS), including…
COVID-19 was the likely trigger of atypical hemolytic uremic syndrome (aHUS) in a boy found to carry a mutation…